Wei Liu, CEO of BioMap, said BioMap plans to seek a public listing in Hong Kong within a year and a half, and added that Hong Kong is the preferred listing destination for technology companies in the early stages of entrepreneurship, according to Bloomberg.Related NewsBofAS Predicts WUXI APPTEC to Continue Gaining Mkt Shr; TP Raised to HKD123